Aminopyrimidine derivatives as LRRK2 inhibitors
US8354420B2 · kind B2 · utility
14Cited by
41References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2011 |
| Grant date | Jan 15, 2013 |
| Priority date | — |
| Expiry date | Jun 1, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the formula I:or pharmaceutically acceptable salts thereof,wherein m, n. X, R1, R2, R3, R5, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.